SIFROL 1.05 mg, extended-release tablet 30 tablets
Brand page: Sifrol (pramipexole) — all forms and strengths in France
Active ingredients: Pramipexole dihydrochloride hydrate, Pramipexole
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIFROL 1,05 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC de 30 comprimé(s)
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Apr 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60267171CIP73974978CIP133400939749785Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PRAMIPEXOLE (DICHLORHYDRATE DE) MONOHYDRATÉcomprimé | 1,5 mg · un comprimé | SA |
| PRAMIPEXOLE BASEcomprimé | 1,05 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.